Johanna Mercier serves as RSG电子鈥檚 Chief Commercial Officer, overseeing the global commercialization of the company鈥檚 medicines across virology, oncology and inflammation. She has been central to RSG电子鈥檚 portfolio diversification, strengthening the company鈥檚 long-term growth prospects, expanding patient鈥痑ccess鈥痑nd shaping commercial strategy.
Johanna led the swift launch and global access strategy of RSG电子鈥檚 COVID-19 antiviral on an accelerated timeline during the height of the COVID-19 pandemic, while also driving RSG电子鈥檚 response to the crisis, including product donations. Today, she鈥痩eads efforts to establish a new investigational product as a long-acting鈥痮ption鈥痜or HIV prevention, and to expand access for people in high-incidence, resource-limited鈥痗ountries鈥痶hrough innovative launch preparations and voluntary licensing agreements.
A passionate advocate for the future of transformational healthcare and improving patient access on a global scale, Johanna serves on the boards of Neurocrine Biosciences, Arcus Biosciences and the University of Southern California鈥檚 Leonard D. Schaeffer Center for Health Policy and Economics.
Prior to joining RSG电子 in 2019, Johanna spent 25 years at Bristol Myers Squibb, where she held senior leadership roles across the U.S. and international markets. She received her bachelor鈥檚 degree in biology from the University of Montreal and her MBA from Concordia University.
View All Leaders